Here's the live share price of Dr. Lalchandani Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Dr. Lalchandani Labs has gained 4.09% CAGR. Over the past year, the corresponding return has been 12.07%.
Dr. Lalchandani Labs’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Dr. Lalchandani Labs | -4.99 | -14.54 | -8.48 | 57.03 | 12.07 | -10.49 | 4.09 |
| Max Healthcare Institute | -6.49 | -4.54 | -6.50 | -5.39 | 2.03 | 35.41 | 50.81 |
| Apollo Hospitals Enterprise | -1.90 | -8.02 | -9.05 | 4.81 | -0.66 | 14.58 | 24.17 |
| Fortis Healthcare | -4.01 | -13.12 | -6.85 | 19.83 | 24.49 | 45.39 | 44.16 |
| Narayana Hrudayalaya | -0.60 | 6.01 | 5.66 | 11.59 | 47.44 | 36.84 | 38.79 |
| Aster DM Healthcare | -2.65 | -5.68 | 2.14 | 11.44 | 33.97 | 41.10 | 31.38 |
| Global Health | -4.67 | -4.32 | -15.79 | -0.15 | 2.90 | 37.82 | 23.52 |
| Krishna Institute of Medical Sciences | 3.81 | -1.03 | -4.05 | 6.24 | 16.63 | 33.06 | 28.94 |
| Dr. Lal Pathlabs | -3.13 | -4.27 | -9.26 | 5.99 | 1.60 | 6.63 | 6.18 |
| Dr. Agarwals Health Care | -4.35 | -2.42 | 20.30 | 45.26 | 25.13 | 7.76 | 4.59 |
| Rainbow Childrens Medicare | -0.87 | -3.18 | -11.42 | -3.33 | -19.64 | 21.46 | 24.50 |
| Vijaya Diagnostic Centre | 5.11 | 3.48 | -2.56 | 10.05 | -6.79 | 31.73 | 11.30 |
| Healthcare Global Enterprises | 0.36 | -6.44 | 2.91 | 29.65 | 42.59 | 32.75 | 37.24 |
| Metropolis Healthcare | -0.37 | -5.20 | -13.84 | 13.75 | -8.40 | 9.81 | -0.72 |
| Jupiter Life Line Hospitals | -1.70 | -7.47 | -0.54 | -1.89 | -5.15 | 10.10 | 5.95 |
| Thyrocare Technologies | -12.58 | -5.11 | -3.86 | 28.57 | 26.35 | 26.21 | 4.19 |
| Yatharth Hospital & Trauma Care Services | -10.93 | -16.41 | -10.76 | 35.33 | 11.24 | 27.15 | 15.50 |
| Kovai Medical Center and Hospital | -3.09 | -5.33 | -6.88 | -6.38 | 5.70 | 49.20 | 38.96 |
| Indraprastha Medical Corporation | -3.79 | -18.41 | 1.14 | 12.88 | -2.36 | 79.52 | 55.88 |
| Artemis Medicare Services | -6.44 | 9.26 | 18.07 | -1.65 | -20.87 | 51.65 | 68.96 |
Over the last one year, Dr. Lalchandani Labs has gained 12.07% compared to peers like Max Healthcare Institute (2.03%), Apollo Hospitals Enterprise (-0.66%), Fortis Healthcare (24.49%). From a 5 year perspective, Dr. Lalchandani Labs has underperformed peers relative to Max Healthcare Institute (50.81%) and Apollo Hospitals Enterprise (24.17%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 22 | 21.58 |
| 10 | 22.2 | 22.21 |
| 20 | 23.6 | 22.49 |
| 50 | 20.95 | 20.88 |
| 100 | 17.05 | 19.23 |
| 200 | 18.42 | 19.31 |
In the latest quarter, Dr. Lalchandani Labs saw a drop in promoter holding to 31.15%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 68.84% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Dec 02, 2025, 8:33 PM IST | Dr. Lalchandani Labs - Board Meeting Intimation for Considering Of Raising Of Funds Through A Rights Issue And/Or Any Other P |
| Nov 15, 2025, 12:02 AM IST | Dr. Lalchandani Labs - Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended September 2025 |
| Nov 15, 2025, 12:00 AM IST | Dr. Lalchandani Labs - Unaudited Financials Results For The Half Year Ended September 30, 2025 |
| Nov 10, 2025, 10:57 PM IST | Dr. Lalchandani Labs - Board Meeting Intimation for Consider And Approve Financial Statements For The Half Year Ended 30.09.2 |
| Oct 10, 2025, 9:06 PM IST | Dr. Lalchandani Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Dr. Lalchandani Labs Ltd. is a Public Limited Listed company incorporated on 02/08/2017 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L85320DL2017PLC321605 and registration number is 321605. Currently Company is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company's Total Operating Revenue is Rs. 4.45 Cr. and Equity Capital is Rs. 4.33 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Lalchandani Labs is ₹19.22 as on Dec 04, 2025.
The Dr. Lalchandani Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Dr. Lalchandani Labs is ₹8.33 Cr as on Dec 04, 2025.
Today’s highest and lowest price of Dr. Lalchandani Labs are ₹19.22 and ₹19.22.
The 52-week high/low is the highest and lowest price at which Dr. Lalchandani Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Lalchandani Labs is ₹0.00 and 52-week low of Dr. Lalchandani Labs is ₹0.00 as on Dec 04, 2025.
The Dr. Lalchandani Labs has shown returns of -4.99% over the past day, -14.54% for the past month, -8.48% over 3 months, 12.07% over 1 year, -10.49% across 3 years, and 4.09% over 5 years.
P/E ratio of and PB ratio of Dr. Lalchandani Labs are 0.00 and 0.84 on Dec 04, 2025. While the company gives a dividend yield of 0.00 per annum.